| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 | 1,957 | 2,064 | 2,168 | 2,113 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 | 1,398 | 1,505 | 1,560 | 1,577 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 | 559 | 559 | 608 | 536 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % | 27 % | 26 % | 27 % | 24 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 | 403 | 400 | 446 | 365 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 | 84 | 93 | -45 | 64 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 | 3.10 |
Max Healthcare Institute
Max Healthcare Institute
1,012.50
-2.80
(-0.28%)
Market Cap
98,529.92 Cr
PE Ratio
69.62
Volume
18,35,293.00
Day High - Low
1,024.60 - 1,007.40
52W High-Low
1,314.30 - 903.00
Key Fundamentals
Market Cap
98,529.92 Cr
EPS
11.07
PE Ratio
69.62
PB Ratio
9.83
Book Value
103.30
EBITDA
2,004.40
Dividend Yield
0.15 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
11.47
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from22 analysts
Actual
Company News
View All News
Max Healthcare Institute Limited's NRC approved allotment of 51,287 equity shares of ₹10 each to eligible employees on May 1, 2026. Paid-up capital increased to ₹973,24,37,890 with total shares at 97,32,43,789.
Max Healthcare Institute received GST rectification order on April 21, 2026, withdrawing entire demand of ₹55,20,45,266 related to alleged excess Input Tax Credit availment.
HSBC Sets ₹1,125 Target for Max HealthcareApr 21, 2026
HSBC maintains Buy rating on Max Healthcare Institute with ₹1,125 target price, citing expected pickup in elective procedures and continued expansion plans for Q4FY26.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,097.00 | #1 1,16,422.44 | 60.40 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 68.54 | |
1,012.50 | #2 98,529.92 | #6 69.62 | #3 7,184.10 | #1 28.68 | #2 1,076 | #4 26.01 | 55.30 | |
952.35 | 71,898.44 | 72.94 | 7,849.70 | 13.25 | 809 | -22.38 | 64.64 | |
742.40 | 38,465.31 | 89.59 | 4,643.22 | 8.32 | 384 | #1 79.65 | 65.49 | |
1,820.30 | 37,199.80 | 48.84 | 5,575.00 | 12.29 | 790 | -34.33 | 56.58 | |
1,200.60 | 32,270.97 | 63.55 | 3,771.40 | 12.59 | 481 | -33.52 | 67.28 | |
717.60 | 28,713.97 | 89.90 | 3,067.00 | 21.98 | 415 | -43.89 | 66.13 | |
454.60 | 14,402.07 | 89.01 | 1,757.00 | 27.64 | 110 | 54.61 | 56.81 | |
1,304.50 | 13,248.39 | 50.49 | 1,566.90 | 17.46 | 244 | 7.26 | 63.97 | |
249.75 | 10,787.47 | #1 39.44 | 1,426.00 | 12.90 | 213 | 15.54 | 73.89 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
28.68 %
Net Income Growth
1.73 %
Cash Flow Change
30.10 %
ROE
-8.82 %
ROCE
-11.54 %
EBITDA Margin (Avg.)
-6.75 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 2,915 | 1,125 | 1,000 | 1,943 | 1,706 | 1,593 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 |
| Investments | 143 | 0 | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 2 | 3 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 913 | 1,981 | 2,020 | 2,810 | 2,661 | 2,809 |
| Total Equity & Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,010 | 777 | 757 | 1,046 | 1,249 | 1,814 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 411 | 2,129 | 2,149 | 1,647 | 2,343 | 4,020 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 2,553 | 5,639 | 6,283 | 7,410 | 8,408 | 9,381 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | -211 | 516 | -318 | 893 | -395 | -319 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -2,641 | 206 | -764 | -102 | -1,253 | -1,614 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 77 | 118 | 741 | 1,284 | 1,122 | 1,459 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 2,353 | 191 | -294 | -289 | -264 | -164 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.72 % | 23.71 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % | 54.74 % | 54.76 % | 51.80 % | 50.55 % | 45.39 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % | 17.58 % | 17.42 % | 20.03 % | 21.20 % | 26.32 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % | 3.31 % | 3.42 % | 3.08 % | 3.13 % | 3.27 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % | 0.63 % | 0.66 % | 1.35 % | 1.38 % | 1.31 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 | 1,80,891 | 2,03,837 | 2,16,996 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.16 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2023 |  Dividend | ₹ 1.00 /share | 08 Sept 2023 | 519.90 | 602.65 |
| 27 Sept 2023 |  Annual General Meeting | NA | 27 Sept 2023 | 553.60 | 566.10 |
| 23 Aug 2024 | Dividend | ₹ 1.50 /share | 23 Aug 2024 | 835.15 | 869.30 |
| 20 Sept 2024 | Annual General Meeting | NA | 20 Sept 2024 | 882.75 | 984.55 |
| 05 Nov 2024 |  Quarterly Result Announcement | NA | 05 Nov 2024 | 994.50 | 1,036.60 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,082.95 | 1,025.90 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 1,159.90 | 1,187.10 |
| 04 Jul 2025 | Dividend | ₹ 1.50 /share | 04 Jul 2025 | 1,187.10 | 1,301.40 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 1,190.20 | 1,274.30 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 1,272.30 | 1,260.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 1,135.30 | 1,098.00 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 975.50 | 1,026.30 |
Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
8 days ago
8 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 21, 2026
Apr 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 12, 2026
Apr 12, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 11, 2026
Apr 11, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateApr 08, 2026
Apr 08, 2026Announcement under Regulation 30 (LODR)-AcquisitionApr 08, 2026
Apr 08, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 08, 2026
Apr 08, 2026Outcome Of Board MeetingApr 08, 2026
Apr 08, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026HonBle National Company Law Tribunal Order For Voluntary Liquidation Of ET Planners Private LimitedMar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 17, 2026
Mar 17, 2026Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Mar 17, 2026
Mar 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Mar 02, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 21, 2026
Feb 21, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 20, 2026
Feb 20, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2026
Feb 12, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Feb 06, 2026Audio Recording Of Earnings Call Held On February 6 2026Feb 06, 2026
Feb 06, 2026Presentation On Earnings UpdateFeb 05, 2026
Feb 05, 2026Board Meeting Outcome for Meeting Held On February 5 2026Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Feb 05, 2026Results - Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 04, 2026
Feb 04, 2026Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Feb 04, 2026
Feb 04, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Jan 29, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Jan 28, 2026Board Meeting Intimation for Consideration And Approval Of Financial ResultsJan 28, 2026
Jan 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 02, 2026
Jan 02, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 19, 2025
Dec 19, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-AcquisitionDec 18, 2025
Dec 18, 2025Outcome Of Board MeetingDec 18, 2025
Dec 18, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 09, 2025
Dec 09, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 03, 2025
Dec 03, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2025
Nov 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Nov 19, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 17, 2025
Nov 17, 2025Audio Recording Of Earnings Call Held On November 17 2025Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2025
Nov 16, 2025Presentation On Earnings UpdateNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Meeting Held On November 14 2025Nov 14, 2025
Nov 14, 2025Results - Financial Results For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 55.30
ATR(14)
Less Volatile 25.38
STOCH(9,6)
Neutral 77.72
STOCH RSI(14)
Neutral 55.85
MACD(12,26)
Bullish 2.57
ADX(14)
Weak Trend 18.26
UO(9)
Bearish 55.13
ROC(12)
Downtrend And Accelerating -0.76
WillR(14)
Overbought -17.63
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and...more
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
